NAD+ for Dogs: What It Is and Why It Matters

As pet parents, we are always looking for ways to help our dogs have more good days as they age. NAD+ and the precursors that support it are an area of active scientific interest in cellular health. This guide covers what NAD+ actually does, what the research does and does not show in dogs, and how to read a label when you are comparing products.

How to choose an NAD+ supplement for a dog

Short answer: three checks settle most of it. Look for a printed milligram dose of the actual NAD+ precursor, no proprietary blend hiding how much you are really getting, and a dry format. NAD+ precursors like NR and NMN are sensitive to heat and moisture, so a dry powder better protects the active than a chew, gummy, or ready-to-drink liquid, which sit in moisture the whole time they are on the shelf. Stabilized and liposomal products can slow that down, so this is a rule of thumb about format, not a verdict on any one brand.

You cannot judge a dose you cannot see. If the label gives you a blend weight instead of a per-ingredient milligram figure, you have no way to compare it to the amounts used in published research.

What is in LongTails NAD+ Precursor

What buyers ask	LongTails NAD+ Precursor
NAD+ precursor and dose	200 mg Nicotinamide Riboside Chloride (NR) per scoop, printed on the label
Other active	1,500 mg hydrolyzed collagen, Type I & III (bovine)
Other ingredients	Beef bone broth powder and beef liver powder. Both are listed on the label as inactive, with no milligram amount
Proprietary blends	None. Two actives, both disclosed
Format	Dry powder. 30 scoops per jar, up to 60 days of use (4 g scoop, net weight 127 g / 4.48 oz)
Free from	Fillers, flavors, binders
Made	cGMP facility, USA
Price	$39.95 per jar at longtails.com
Delivery	Amazon handles our shipping, so most orders arrive in 2 days. Subscriptions ship on your schedule, always with free shipping
Subscription	Skip, change frequency, or cancel from your account without calling support

On the dose: 200 mg of NR is within the 100–300 mg per day range shown to raise blood NAD+ in human randomized trials, and far above the trace amounts common in the category. NR is the most-studied NAD+ precursor in human research, with 25+ published human trials. No published canine study isolates an NAD+ precursor for aging or cognition, so we describe the mechanism and the human evidence, not a proven canine outcome.

See the full label and ingredient panel →

What is NAD+ and why does it matter for dogs?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every cell of your dog’s body. Think of it as a cellular battery that powers a set of fundamental jobs:

• Cellular energy production in the mitochondria
• DNA repair and maintenance, through enzymes called sirtuins and PARPs
• Cellular communication
• Metabolic processes

NAD+ falls with age in multiple tissues studied in rodents, and in blood in humans. No canine aging study has been published, so we cannot say the same from direct dog data. The biology is expected to apply, and that expectation, not proof in dogs, is what the category is built on. When NAD+ runs low, cellular energy production and DNA repair are both compromised.

What NAD+ precursors do, and what the evidence supports

You do not supplement NAD+ directly in any useful way. NAD+ is a large, charged molecule, and taken by mouth it is largely broken down in the digestive tract into smaller building blocks before absorption. Cells generally take up precursors instead. That is why credible NAD+ supplements are built on a precursor such as nicotinamide riboside (NR) or nicotinamide mononucleotide (NMN), rather than on NAD+ itself.

Blood NAD+

NR reliably raises blood NAD+ in human trials. Muscle and other tissue results are inconsistent, so blood is the honest limit of that claim. In dose-ranging work, 100 mg per day raised blood NAD+ by about 22 percent and 300 mg by about 51 percent.

Depth of research

NR is the most-studied NAD+ precursor in human research, with 25+ published human trials, roughly three times the NMN literature as of 2023. That matters when you are choosing between precursors: it is the one with the most human data behind it.

Tolerability

Human NR trials show clean tolerability, with no serious adverse events reported, including in dose-ranging studies.

Cellular energy

NAD+ is required for the mitochondria to convert food into usable cellular energy. Supporting these cellular systems is the rationale behind the formulation. Energy, eagerness for walks, a return to play, comfort on stairs and general alertness are the things owners tend to watch. They are observations, not promises.

What the canine evidence actually says

This is where most articles on this topic overreach, so it is worth being precise.

There is one published canine randomized controlled trial in this space (Scientific Reports, 2024). It tested a senolytic combined with an NAD+ precursor, not nicotinamide riboside on its own and not our formula. It did not measure NAD+ levels. Its objective cognitive testing showed no significant benefit; only the owner-reported questionnaire moved. It was funded by the product’s maker.

So that study does not isolate the precursor, and it is not evidence of a canine cognition benefit. Any article that presents it as a breakthrough showing improved cognition in senior dogs has misread it. No published canine study isolates an NAD+ precursor for aging or cognition.

What we are left with is a well-described mechanism, a substantial human literature on NR and blood NAD+, and a reasonable expectation that the biology carries over to dogs. That is an honest reason to consider a precursor. It is not a promise of an outcome.

Signs owners often act on

Dogs do not tell us when something changes, so owners usually notice behavior first. These are the changes that most often prompt a look at cellular support. None of them are diagnostic, and anything new or sudden is a reason to see your veterinarian rather than to reach for a supplement.

Energy and routine

• Less enthusiasm for regular activities
• Slower recovery after exercise or play
• Changes in sleep patterns or restlessness
• Less interest in toys or interactive play

Movement

• Slower movement or hesitation on stairs and jumps
• Longer recovery time after exercise

If you are seeing confusion, disorientation in familiar places, or a change in how your dog interacts with the family, that warrants a veterinary conversation. Those signs are associated with canine cognitive dysfunction, and no NAD+ precursor has been shown to improve cognition in dogs.

Choosing an NAD+ supplement for your dog

Beyond the three checks above, these are the practical things worth comparing:

Quality indicators:

• A clean ingredient list with no unnecessary fillers
• Third-party testing for purity and potency
• Transparent manufacturing practices
• An appropriate dosage form for dogs

Essential components:

• A named NAD+ precursor with its milligram amount printed
• A format that protects the active from heat and moisture
• A formulation your dog will actually accept
• Size-appropriate dosing

LongTails NAD+ Precursor is built to those checks: 200 mg NR per scoop, printed, with no proprietary blend.

Administration considerations:

• Ease of dosing for your dog’s size
• Palatability and acceptance
• A convenient daily schedule
• Storage requirements

Safety and administration

Dosing guidelines:

• Start with the dose on the label for your dog’s weight
• Introduce it gradually rather than all at once
• Adjust only under veterinary guidance
• Keep it consistent day to day

Best practices:

• Give with food unless otherwise directed
• Establish a regular schedule
• Watch your dog’s response and behavior
• Keep a simple log of what you notice

Safety considerations:

• Speak to your veterinarian before starting
• Discuss existing health conditions or medications
• Watch for any change in behavior or appetite
• Report concerns to your veterinarian promptly

Frequently asked questions about NAD+ for dogs

How long before I see results?

LongTails is proactive daily support, not a quick fix. Keep it in the routine and give it time. Every dog is different and individual experiences vary. There is no published canine trial that establishes a timeline, so treat any specific number of weeks you see quoted online with caution.

Is NAD+ safe for long-term use in dogs?

Nicotinamide riboside has shown clean tolerability in human trials, with no serious adverse events, including in dose-ranging studies. No long-term canine study has been published. Follow the label dose, introduce it gradually, and speak to your veterinarian if your dog has a health condition or takes medication.

Does NAD+ help with cognitive decline or dog dementia?

No published canine study shows an NAD+ precursor improving cognition. The one canine trial often cited (Scientific Reports, 2024) tested a senolytic combined with an NAD+ precursor, did not measure NAD+, and its objective cognitive testing showed no significant benefit. The three human NR trials that measured cognition were also null, at doses five to ten times ours. The claim we can support is the mechanism: NAD+ is central to cellular energy and DNA repair. We will not claim a brain benefit we cannot evidence.

Can young dogs take an NAD+ precursor?

It is not restricted to seniors, but the interest in NAD+ is driven by age-related biology, so most owners start when a dog reaches its senior years. Ask your veterinarian about your own dog.

How much NAD+ precursor should a dog get?

There is no established canine dose, because no canine dosing study has been published. LongTails uses 200 mg of nicotinamide riboside per scoop, which sits inside the 100 to 300 mg per day range shown to raise blood NAD+ in human randomized trials. Follow the label and your veterinarian.

What should I look for on the label?

A printed milligram dose of the precursor itself, no proprietary blend, and a dry format that better protects the active from heat and moisture. If the label shows a blend weight instead of per-ingredient milligrams, you cannot compare it to the amounts used in research.

Getting started

1. Speak to your veterinarian
2. Choose a product with a printed dose and no proprietary blend
3. Start at the label dose and introduce it gradually
4. Keep a simple log of energy, walks and play over the following weeks

See LongTails NAD+ Precursor →

This article is for informational purposes only. It is not, nor is it intended to be, a substitute for professional medical or veterinary advice, diagnosis, or treatment and should never be relied upon or perceived as specific medical or veterinary advice.

References

Conze, D., Brenner, C., & Kruger, C. L. (2019). Safety and metabolism of long-term administration of NIAGEN (nicotinamide riboside chloride) in a randomized, double-blind, placebo-controlled clinical trial of healthy overweight adults. Scientific Reports, 9, 9772. https://doi.org/10.1038/s41598-019-46120-z

Trammell, S. A. J., et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications, 7, 12948. https://doi.org/10.1038/ncomms12948

Damgaard, M. V., & Treebak, J. T. (2023). What is really known about the effects of nicotinamide riboside supplementation in humans. Science Advances, 9(29). https://doi.org/10.1126/sciadv.adi4862

Peluso, A., Damgaard, M. V., Mori, M. A. S., & Treebak, J. T. (2021). Age-dependent decline of NAD+ — universal truth or confounded consensus? Nutrients, 14(1), 101. https://doi.org/10.3390/nu14010101

Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265), 1208–1213. https://doi.org/10.1126/science.aac4854

McKay, K., et al. (2024). Randomized controlled trial of a senolytic plus an NAD+ precursor combination in senior dogs. Scientific Reports, 14. https://www.nature.com/articles/s41598-024-63031-w — objective cognitive testing showed no significant difference; only the owner-completed questionnaire moved. The trial did not measure NAD+, did not isolate the precursor, and was funded by the product’s maker.

Campbell, M. T. (2019). Stability of nicotinamide riboside chloride in aqueous solution. Food & Nutrition Research. https://doi.org/10.29219/fnr.v63.3419

Bogan, K. L., & Brenner, C. (2008). Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual Review of Nutrition, 28, 115–130. https://doi.org/10.1146/annurev.nutr.28.061807.155443